EASL School: Clinical problems in management of cirrhosis and portal hypertension related complications
The objective of the School is that of fostering the clinical formation of young hepatologists in the area of advanced liver disease, and in particular in the field of portal hypertension, where important advancements are in progress. The course is scheduled for 2022, a few months following the Baveno 7 consensus conference on portal hypertension, where new statements and related clinical practice guidelines are expected.
The theme of the course will be focused on complications related to portal hypertension, which constitute most of the complex clinical problems in the management of patients with advanced liver disease. These include diuretic-refractory ascites, frequently recurrent hepatic encephalopathy, antibiotic-resistant bacterial infections, management of patients eligible for transplantation but outside the MELD criteria.
Learning objectives
- To foster the clinical formation in portal hypertension
- To obtain a comprehensive view of the complexities of advanced liver disease and its treatment
Target audience
- Hepatologists
- Clinical Scientists
- Transplant hepatologists
Top 3 reasons to attend
- The presence of a group of experts covering the full range of complications related to portal hypertension
- The timing of the School a few months after the latest Baveno consensus conference
- The variety of selected topics, that cover most aspects of advanced liver disease
